{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:48:11Z","timestamp":1794084491291,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573445"],"award-info":[{"award-number":["82573445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373242"],"award-info":[{"award-number":["82373242"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373187"],"award-info":[{"award-number":["82373187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,7]]},"DOI":"10.1038\/s41388-026-03932-4","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:08:10Z","timestamp":1785841690000},"page":"4065-4076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumor microenvironment-simulated organoids for personalized therapy prediction in head and neck squamous cell carcinoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Jianguo","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8316-5809","authenticated-orcid":false,"given":"Guiquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3932_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6:92.","journal-title":"Nat Rev Dis Prim"},{"key":"3932_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16:669\u201383.","journal-title":"Nat Rev Clin Oncol"},{"key":"3932_CR3","doi-asserted-by":"crossref","unstructured":"Li B, Xie S, Han J, Cao H, Lin Z, Hu H, et al. Neoadjuvant chemoimmunotherapy in resectable locally advanced oral squamous cell carcinoma: a single-center retrospective cohort study. Int J Surg. 2025;111:781\u201390.","DOI":"10.1097\/JS9.0000000000001891"},{"key":"3932_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jop.13628","volume":"54","author":"K Sabando-Criollo","year":"2025","unstructured":"Sabando-Criollo K, Fern\u00e1ndez-Cuya MS, Lozano-Burgos C, Mart\u00ednez-Flores R, Gonz\u00e1lez-Arriagada WA. Nonmetastatic lymph node histological architecture is associated with metastasis, recurrence, and survival in oral squamous cell carcinoma. J Oral Pathol Med. 2025;54:371\u20139.","journal-title":"J Oral Pathol Med"},{"key":"3932_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100806","volume":"60","author":"V Van den Bossche","year":"2022","unstructured":"Van den Bossche V, Zaryouh H, Vara-Messler M, Vignau J, Machiels J-P, Wouters A, et al. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resist Updat. 2022;60:100806.","journal-title":"Drug Resist Updat"},{"key":"3932_CR6","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1200\/JCO.2015.61.2929","volume":"33","author":"SB Chinn","year":"2015","unstructured":"Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33:3269\u201376.","journal-title":"J Clin Oncol"},{"key":"3932_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, et al. NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022;20:224\u201334.","journal-title":"J Natl Compr Canc Netw"},{"key":"3932_CR8","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R, Souli\u00e8res D, Tahara M, de Castro G, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394:1915\u201328.","journal-title":"Lancet"},{"key":"3932_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJMoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med. 2025;393:37\u201350.","journal-title":"N Engl J Med"},{"key":"3932_CR10","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1097\/JS9.0000000000000489","volume":"109","author":"Y Huang","year":"2023","unstructured":"Huang Y, Sun J, Li J, Zhu D, Dong M, Dou S, et al. Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). Int J Surg. 2023;109:2220\u20137.","journal-title":"Int J Surg"},{"key":"3932_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101930","volume":"6","author":"H-M Liu","year":"2025","unstructured":"Liu H-M, Xiong X-P, Yu Z-L, Shao Z, Chen G-L, Liu Y-T, et al. Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: randomized, two-arm, phase 2 trial. Cell Rep Med. 2025;6:101930.","journal-title":"Cell Rep Med"},{"key":"3932_CR12","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586\u201397.","journal-title":"Cell"},{"key":"3932_CR13","doi-asserted-by":"crossref","unstructured":"Millen R, De Kort WWB, Koomen M, van Son GJF, Gobits R, Penning de Vries B, et al. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification. Med. 2023;4:290\u2013310.e212.","DOI":"10.1016\/j.medj.2023.04.003"},{"key":"3932_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","volume":"9","author":"E Driehuis","year":"2019","unstructured":"Driehuis E, Kolders S, Spelier S, L\u00f5hmussaar K, Willems SM, Devriese LA, et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 2019;9:852\u201371.","journal-title":"Cancer Discov"},{"key":"3932_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115100","volume":"213","author":"A-S Fisch","year":"2024","unstructured":"Fisch A-S, Pestana A, Sachse V, Doll C, Hofmann E, Heiland M, et al. Feasibility analysis of using patient-derived tumour organoids for treatment decision guidance in locally advanced head and neck squamous cell carcinoma. Eur J Cancer. 2024;213:115100.","journal-title":"Eur J Cancer"},{"key":"3932_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24:523\u201339.","journal-title":"Nat Rev Cancer"},{"key":"3932_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu H, Jiao D, Liu A, Wu K. Tumor organoids: applications in cancer modeling and potentials in precision medicine. J Hematol Oncol. 2022;15:58.","journal-title":"J Hematol Oncol"},{"key":"3932_CR18","doi-asserted-by":"crossref","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175:1972-88.e1916.","DOI":"10.1016\/j.cell.2018.11.021"},{"key":"3932_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114365","volume":"187","author":"J Zhang","year":"2022","unstructured":"Zhang J, Tavakoli H, Ma L, Li X, Han L, Li X. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment. Adv Drug Deliv Rev. 2022;187:114365.","journal-title":"Adv Drug Deliv Rev"},{"key":"3932_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/0022034520956614","volume":"100","author":"H Zhao","year":"2021","unstructured":"Zhao H, Jiang E, Shang Z. 3D Co-culture of cancer-associated fibroblast with oral cancer organoids. J Dent Res. 2021;100:201\u20138.","journal-title":"J Dent Res"},{"key":"3932_CR21","doi-asserted-by":"crossref","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 2018;174:1586\u201398.e1512.","DOI":"10.1016\/j.cell.2018.07.009"},{"key":"3932_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4238-4","volume":"18","author":"S Tsai","year":"2018","unstructured":"Tsai S, McOlash L, Palen K, Johnson B, Duris C, Yang Q, et al. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. BMC Cancer. 2018;18:335.","journal-title":"BMC Cancer"},{"key":"3932_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41416-022-01839-x","volume":"127","author":"G Zhou","year":"2022","unstructured":"Zhou G, Lieshout R, van Tienderen GS, de Ruiter V, van Royen ME, Boor PPC, et al. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. Br J Cancer. 2022;127:649\u201360.","journal-title":"Br J Cancer"},{"key":"3932_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Li P, Wang L, Li M, Ge Z, Noordam L, et al. Cancer-associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance. Cell Mol Gastroenterol Hepatol. 2021;11:407\u201331.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3932_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","volume":"41","author":"S Schuth","year":"2022","unstructured":"Schuth S, Le Blanc S, Krieger TG, Jabs J, Schenk M, Giese NA, et al. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J Exp Clin Cancer Res. 2022;41:312.","journal-title":"J Exp Clin Cancer Res"},{"key":"3932_CR26","doi-asserted-by":"crossref","unstructured":"Sase M, Sato T, Sato H, Miya F, Zhang S, Haeno H, et al. Comparative analysis of tongue cancer organoids among patients identifies the heritable nature of minimal residual disease. Dev Cell. 2025;60:396-413.e396.","DOI":"10.1016\/j.devcel.2024.10.007"},{"key":"3932_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2026.106520","volume":"184","author":"J Gan","year":"2026","unstructured":"Gan J, Meng W, Yang D, Feng X, Zhu G. Comparative analysis of patient-derived organoids among oral squamous cell carcinoma and mucosa identifies the distinct features. Arch Oral Biol. 2026;184:106520.","journal-title":"Arch Oral Biol"},{"key":"3932_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102129","volume":"6","author":"MR Lee","year":"2025","unstructured":"Lee MR, Kang S, Lee J, Kong S-Y, Kim Y, Lee Y-S, et al. Organoid morphology-guided classification for oral cancer reveals prognosis. Cell Rep Med. 2025;6:102129.","journal-title":"Cell Rep Med"},{"key":"3932_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106571","volume":"146","author":"SY Choi","year":"2023","unstructured":"Choi SY, Shim J, Gu D-e, Kim SY, Kim HJ, Shin D-Y, et al. Clonal evolution of long-term expanding head and neck cancer organoid: impact on treatment response for personalized therapeutic screening. Oral Oncol. 2023;146:106571.","journal-title":"Oral Oncol"},{"key":"3932_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jamaoncol.2015.3638","volume":"2","author":"J McLaughlin","year":"2016","unstructured":"McLaughlin J, Han G, Schalper KA, Carvajal-Hausdorf D, Pelekanou V, Rehman J, et al. Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer. JAMA Oncol. 2016;2:46\u201354.","journal-title":"JAMA Oncol"},{"key":"3932_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamaoncol.2017.0013","volume":"3","author":"DL Rimm","year":"2017","unstructured":"Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, et al. A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non-small cell lung cancer. JAMA Oncol. 2017;3:1051\u20138.","journal-title":"JAMA Oncol"},{"key":"3932_CR32","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","volume":"10","author":"D Sha","year":"2020","unstructured":"Sha D, Jin Z, Budczies J, Kluck K, Stenzinger A, Sinicrope FA. Tumor mutational burden as a predictive biomarker in solid tumors. Cancer Discov. 2020;10:1808\u201325.","journal-title":"Cancer Discov"},{"key":"3932_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein RM, Lee C-H, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet. 2019;51:202\u20136.","journal-title":"Nat Genet"},{"key":"3932_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409\u201313.","journal-title":"Science"},{"key":"3932_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22:159.","journal-title":"Mol Cancer"},{"key":"3932_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"3932_CR37","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, et al. Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses. Cancer Discov. 2023;13:2192\u2013211.","journal-title":"Cancer Discov"},{"key":"3932_CR38","doi-asserted-by":"crossref","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171:1611\u201324.e1624.","DOI":"10.1016\/j.cell.2017.10.044"},{"key":"3932_CR39","doi-asserted-by":"crossref","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, et al. Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40:1550\u201365.e1557.","DOI":"10.1016\/j.ccell.2022.11.005"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03932-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03932-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03932-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:02:16Z","timestamp":1789509736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03932-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":39,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026,10,7]]}},"alternative-id":["3932"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03932-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ethics Committee of West China Hospital of Stomatology (WCHSIRB-D-2022-008) and was performed in accordance with the principles outlined in the Helsinki Declaration and in compliance with relevant laws and institutional guidelines. All donors participating in this study signed informed-consent forms and can withdraw their consent at any time, leading to the prompt disposal of their tissue and any derived material, as well as the cessation of data collection.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}